OnDemand

OMB Interim Final Rule Launches Super Circular Grant

Price: $224 OnDemand

FULFILL ALL YOUR CONTINUING EDUCATION CREDITS FOR $399

Sign up today for an entire year of unlimited access to relevant, timely professional learning courses, including webinars, eLearning courses and OnDemand offerings, and keep your professional credits up to date. All for just $399.

Learn more about the subscription!

SUBSCRIBE NOW

DESCRIPTION

This webinar is designed to provide a brief overview of the requirements for reporting in Federal Grants (OMB Circulars A-110, A-21 and A-133), describe the practical implications of the government’s reporting obligations and the intersections with the transparency obligations in the ACA, and summarize the OMB Uniform Guidance that went into effect in December 2014.

Educational Objectives:
• Provide a brief overview of the requirements for reporting in Federal Grants (OMB Circulars A-110, A-21 and A-133)
• Describe the practical implications of the government’s reporting obligations and the intersections with the transparency obligations in the ACA 
• Summarize the OMB Uniform Guidance that effective December 2014

Who would benefit most from attending this program?
Researchers, administrators, accountants, attorneys, consultants or others responsible for managing federal awards. 

SPEAKERS

F. LISA MURTHA, J.D., CHC, CHRC, SENIOR MANAGEMENT DIRECTOR, FTI CONSULTING

Lisa Murtha is a Senior Managing Director at FTI Consulting and is based in Philadelphia. She is part of the Health Solutions practice. Lisa has over 27 years of experience working on complex clinical research and healthcare compliance issues.  She focuses her practice in corporate ethics and compliance programs, and in both sponsor and research site clinical research compliance which includes Physician Sunshine Act compliance, aggregate/promo spend issues, off-label use issues, issues related to payments to health care professionals, human subject protections, effort reporting/grant accounting, scientific misconduct, conflicts of interest, internal auditing and monitoring, and clinical trial billing and process improvement. Lisa's clients include large and small hospitals and health systems and academic medical centers as well as pharmaceutical and biotechnology companies. She also provides guidance regarding revenue cycle work, billing and coding issues, internal investigations, compliance program effectiveness, corporate governance/ethics, and HIPAA/HITECH/Omnibus Rule related matters. Lisa holds her J.D. from Dickinson School of Law and her B.A. from the Pennsylvania State University.